SCHEMBL19851460

SCHEMBL19851460

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)[nH]c4cc(-c6ccc7[nH]c8ccccc8c7c6)ccc45)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ATM Q13315 1/20 0.49
AHR P35869 1/20 0.45
KIF11 P52732 11/20 0.40
PDE7A Q13946 2/20 0.39
PDE7B Q9NP56 2/20 0.39
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GPR3 P46089 1/20 0.38
HPGD P15428 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29506377 0.97 L3MBTL1 (0.51) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL9891302 0.97 L3MBTL1 (0.51) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL15589128 0.96 KDM4E (0.47) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL15199680 0.96 L3MBTL1 (0.50) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL24304094 0.96 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL29362456 0.96 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL29827404 0.96 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL29410818 0.96 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL261376 0.96 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL15962643 0.96 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, ETV6, LEF1 KDM4E 2538/4885L3MBTL1 3274/4885ATM 3035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.